Evidence map›Paper›PMID 27226170›Full record

ReviewBiomaterials science2016

Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO).

Yaqi Wo, Elizabeth J Brisbois, Robert H Bartlett, Mark E Meyerhoff

Abstract readReview
In one paragraph

Review in Biomaterials science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Wearable nitric oxide-releasing antibacterial insert for preventing device-associated infections.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Article
  16. Article
  17. PreventingACS applied bio materials · 2024
    Article
  18. ACS applied materials & interfaces · 2024
    Article
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yaqi WoDepartment of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA. mmeyerho@umich.edu.
Elizabeth J Brisbois
Robert H Bartlett
Mark E Meyerhoff

Funding

Biocompatible Chemical Sensors Via Nitric Oxide Release/GenerationR01EB000783 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MEYERHOFF, MARK E · 2002 to 2013
$3.1M
Bactericidal, Nonthrombogenic Intravascular CathetersR01HL128337 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BARTLETT, ROBERT H., MEYERHOFF, MARK E · 2015 to 2018
$2.8M
Advanced Thromboresistant/Bactericidal Catheters via Electromodulated NO ReleaseR56HL119403 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MEYERHOFF, MARK E · 2014 to 2014
$554k
Thromboresistant/Bactericidal Intravascular Catheters Based on Electrochemical Nitric Oxide GenerationF32HL127981 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BRISBOIS, ELIZABETH JOY · 2015 to 2017
$102k
NHLBI NIH HHS F32 HL127981NHLBI NIH HHS R01 HL128337NHLBI NIH HHS R56 HL119403NIBIB NIH HHS R01 EB000783
6 · The paper itself

Abstract

Biomedical devices are essential for patient diagnosis and treatment; however, when blood comes in contact with foreign surfaces or homeostasis is disrupted, complications including thrombus formation and bacterial infections can interrupt device functionality, causing false readings and/or shorten device lifetime. Here, we review some of the current approaches for developing antithrombotic and antibacterial materials for biomedical applications. Special emphasis is given to materials that release or generate low levels of nitric oxide (NO). Nitric oxide is an endogenous gas molecule that can inhibit platelet activation as well as bacterial proliferation and adhesion. Various NO delivery vehicles have been developed to improve NO's therapeutic potential. In this review, we provide a summary of the NO releasing and NO generating polymeric materials developed to date, with a focus on the chemistry of different NO donors, the polymer preparation processes, and in vitro and in vivo applications of the two most promising types of NO donors studied thus far, N-diazeniumdiolates (NONOates) and S-nitrosothiols (RSNOs).

Indexed as

AnimalsAnti-Bacterial AgentsAzo CompoundsBacterial AdhesionBiofoulingCoated Materials, BiocompatibleFibrinolytic AgentsHumansNitric OxideNitric Oxide DonorsPlatelet ActivationPolymersS-NitrosothiolsThrombosisAnti-Bacterial AgentsAzo CompoundsCoated Materials, BiocompatiblediazeniumdiolateFibrinolytic AgentsNitric OxideNitric Oxide DonorsPolymersS-Nitrosothiols

Identifiers

PMID27226170
PMCPMC4955746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.